News on this topic
Pfizer asks FDA to clear updated COVID shot for kids under 5: Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5 ...
apnews.com/article/health-business-covid-edb67e3e548e7ff089380c2367f4ccf7
More articles on this subject
Previous
Pfizer asks FDA to clear updated COVID shot for kids under 5: Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5 ...
apnews.com/article/health-business-covid-edb67e3e548e7ff089380c2367f4ccf7
Bird Flu Virus Found in One in Five US Milk Samples, FDA Says: Fragments of the bird flu virus have been found in about one fifth of commercial milk samples ...
bloomberg.com/news/articles/2024-04-26/bird-flu-virus-found-in-one-in-five-us-milk-samples-fda-says
Quick Glance: Key Insights on Bird Flu-Traced Milk Safety
- FDA confirms traces of bird flu in milk, but emphasizes low public risk.
- Although genetic material of the virus was found in milk, tests show no infectious or live form.
- Authorities have not conducted specific studies on bird flu inactivation in cow's milk through pasteurization.
- Experts stress that milk with bird flu traces is safe as long as it is pasteurized and sourced from infected cows.
Why South Korean pop culture rocks and North Korea’s does not: Dictatorship stifles creativity and joy
economist.com/culture/2024/04/22/why-south-korean-pop-culture-rocks-and-north-koreas-does-not
Quick Glance: Kim Leads Rocket Drills for Nuclear Counterattacks
- North Korean leader Kim Jong Un supervised rocket launches simulating nuclear counterattacks.
- The drills showcased the strength of the country's nuclear forces.
- The rockets were described as highly accurate and capable of carrying tactical nuclear warheads.
- The US and South Korea are responding with enhanced military exercises and nuclear deterrence strategies.
US FDA sends warning letter to Cardinal Health for marketing unapproved devices
reut.rs/4bawEqO
Quick Glance: US FDA issues warning to Cardinal Health for marketing unauthorized devices
- Following an inspection of its facility in Illinois, the US health regulatory body issued a warning letter to Cardinal Health for marketing and distributing unauthorized devices from a Chinese manufacturer.
- In 2023, the U.S. Food and Drug Administration advised against using certain syringes manufactured in China due to reports of leaks, breakages, and quality issues, and recently expanded the guidelines.
- Cardinal has not responded to a request for comment from Reuters. The inspection revealed that Cardinal was importing two types of syringes under the Monoject brand.
- These syringes are utilized for injecting or withdrawing fluids from the body, as well as administering fluids or medications through a patient's feeding tube. In November, the agency cautioned healthcare providers and facilities against using Cardinal's Monoject syringes with pain management and syringe pumps.
Alzheimer's drug adoption in US slowed by doctors' skepticism: Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's ...
reuters.com/business/healthcare-pharmaceuticals/alzheimers-drug-adoption-us-slowed-by-doctors-skepticism-2024-04-23/
Quick Glance: Alzheimer's Drug Uptake Hindered by Doctors' Skepticism in US
- The first drug to slow the progression of Alzheimer's, Leqembi by Eisai and Biogen, is facing resistance in the US from doctors who believe the treatment is futile.
- The requirements of Leqembi, such as additional diagnostic tests, twice-monthly infusions, and regular brain scans, have led to slow adoption as many doctors express concerns about efficacy, cost, and risks.
- Despite FDA approval and proven benefits in clinical trials, many doctors still have reservations about Leqembi, hindering the widespread use of the drug.
- The companies behind Leqembi are working to improve physician and patient education to increase acceptance of the medication, aiming to treat 100,000 patients by 2026.
Climate change is slowing Earth’s rotation: This simplifies things for the world’s timekeepers
economist.com/science-and-technology/2024/04/24/climate-change-is-slowing-earths-rotation
Why so many Chinese graduates cannot find work: Our number-crunching suggests that their plight could be much worse than previously thought
economist.com/china/2024/04/18/why-so-many-chinese-graduates-cannot-find-work
Paid articlePaid
FDA Approves Antibiotic to Treat Urinary Infections: Pivmecillinam, which has been used in Europe for decades, will become available next year to women 18 and ...
nytimes.com/2024/04/24/health/fda-urinary-tract-infection-antibiotic.html
Has Taylor Swift peaked?: The musician is at the height of her commercial, but not her creative, power
economist.com/culture/2024/04/24/has-taylor-swift-peaked
Finally, America’s Congress does right by Ukraine: Disaster has been dodged. But the political malaise that delayed the Ukraine funding bill remains
economist.com/leaders/2024/04/20/finally-americas-congress-does-right-by-ukraine
Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda: Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of ...
reuters.com/business/healthcare-pharmaceuticals/merck-raises-2024-profit-forecast-strong-cancer-hpv-drugs-sales-2024-04-25/
Quick Glance: Merck boosts 2024 profit outlook due to Keytruda sales
- Merck & Co. raises annual profit and revenue forecasts based on double-digit growth for the blockbuster cancer drug Keytruda.
- Sales for 2024 are estimated to be between $63.1 billion and $64.3 billion, an increase from the previous forecast.
- Keytruda recorded $6.95 billion in sales in the first quarter, a 20% increase from the previous year.
- Merck also saw strong growth with its vaccine Gardasil, the drug Vaxneuvance, and a successful acquisition of Harpoon Therapeutics in the first quarter of 2024.
US FDA approves ImmunityBio's bladder cancer therapy: The U.S. health regulator approved on Monday ImmunityBio's combination therapy to treat a type of bladder ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-immunitybios-bladder-cancer-therapy-2024-04-22/
What are the obligations of Israel and Hamas to protect civilians?: International Humanitarian Law creates obligations—but contains numerous caveats
economist.com/the-economist-explains/2024/04/24/what-are-the-obligations-of-israel-and-hamas-to-protect-civilians
India’s financial system has improved dramatically in the past decade : There is much more change to come
economist.com/special-report/2024/04/22/indias-financial-system-has-improved-dramatically-in-the-past-decade
InnovationRx: Legislation Could Prevent Pharma Companies From Working With Chinese Contractors
forbes.com/sites/katiejennings/2024/04/17/innovationrx-legislation-could-prevent-pharma-companies-from-working-with-chinese-contractors/
Can anyone pull Boeing out of its nosedive?: The American planemaker needs one hell of a pilot
economist.com/business/2024/04/24/can-anyone-pull-boeing-out-of-its-nosedive
Solicitor General Elizabeth Prelogar again in the spotlight fighting the conservative Supreme Court on abortion
cnn.com/2024/04/24/politics/solicitor-general-elizabeth-prelogar-idaho-abortion/
Quick Glance: Supreme Court Divided on Emergency Abortion Access: Highlights
- The Supreme Court seems divided on access to emergency abortions in states with near-total bans.
- The 1986 Emergency Medical Treatment and Labor Act could impact abortion access in emergencies.
- The debate raises questions about fetal personhood and abortion rights conflict.
- The court's decision could affect abortion access in 14 states with strict abortion bans.
Biden administration issues privacy rule protecting abortion: President Joe Biden's administration issued a final rule on Monday aimed at strengthening privacy ...
reuters.com/world/us/biden-administration-issues-privacy-rule-protecting-abortion-2024-04-22/
Efforts to tackle student protests in America have backfired badly: Police intervention at Columbia has provoked protests at other universities
economist.com/united-states/2024/04/23/efforts-to-tackle-student-protests-in-america-have-backfired-badly
Don’t be gloomy about Tesla and its EV rivals : The industry has had a terrible few months. But demand is likely to pick up
economist.com/leaders/2024/04/24/dont-be-gloomy-about-tesla-and-its-ev-rivals
National Drug Shortages Hit Record Levels : Requesting a refill at the local pharmacy or getting a complete series of a specific chemotherapy is becoming ...
webmd.com/drug-medication/news/20240418/national-drug-shortages-hit-record-levels
Abeona shares tumble as FDA declines to approve skin disorder treatment: Abeona Therapeutics said on Monday the U.S. Food and Drug Administration (FDA) had ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-abeonas-skin-disorder-treatment-2024-04-22/
“We have to make Biden lose”: Arab-Americans are switching to Trump: Anger over Gaza in the swing state of Michigan might cost the president the election
economist.com/1843/2024/04/24/we-have-to-make-biden-lose-arab-americans-are-switching-to-trump
Primary schools in Britain are beginning to close : A baby bust is starting to work its way through the system
economist.com/britain/2024/04/11/primary-schools-in-britain-are-beginning-to-close
Eli Lilly to acquire manufacturing facility from Nexus Pharma: Eli Lilly said on Monday that it will acquire a manufacturing facility from Nexus Pharmaceuticals ...
reuters.com/business/healthcare-pharmaceuticals/eli-lilly-acquire-manufacturing-facility-nexus-pharma-2024-04-22/
How Russia targeted France and radicalised Emmanuel Macron: He is now one of Europe’s leading Russia hawks
economist.com/europe/2024/04/18/how-russia-targeted-france-and-radicalised-emmanuel-macron
Two years of war have impoverished many Ukrainians: The elderly, the displaced and the disabled are the worst affected
economist.com/europe/2024/04/21/two-years-of-war-have-impoverished-many-ukrainians
Israel should not rush to strike back at Iran: Instead it should try a novel response to Iran’s missile attack: restraint
economist.com/leaders/2024/04/18/israel-should-not-rush-to-strike-back-at-iran
Quick Glance: Israel artist calls for Gaza ceasefire
- The representative of Israel at the international art fair is calling for an immediate ceasefire in Israel’s war on Gaza.
- Ruth Patir’s video installation called (M)otherland was scheduled to open on Saturday at Israel’s national pavilion at the international art show but will remain closed for now.
- Patir stated on her website that the artist and curators are showing solidarity with the families of the hostages and the large community in Israel calling for change, rather than canceling themselves or the exhibition.
- It is believed that there are still individuals in Gaza, including 129 captives taken during the attacks led by Hamas on Israel on October 7, with 34 of them presumed dead.
Gilead posts quarterly loss on acquisition charge, revenue rises 5%: Gilead Sciences reported a first-quarter loss on Thursday after taking a $3 ...
reuters.com/business/healthcare-pharmaceuticals/gilead-posts-quarterly-loss-revenue-rises-5-2024-04-25/
Israel responds to Iran’s barrage with a symbolic strike: Both sides have a chance to de-escalate their conflict, at least for now
economist.com/middle-east-and-africa/2024/04/19/israel-responds-to-irans-barrage-with-a-symbolic-strike
Congress tells China: sell TikTok or we’ll ban it: Only America’s courts can save the video app now
economist.com/business/2024/04/24/congress-tells-china-sell-tiktok-or-well-ban-it
Reasons to be cheerful about Generation Z: They are not doomed to be poor and anxious
economist.com/leaders/2024/04/18/reasons-to-be-cheerful-about-generation-z
Eli Lilly weight-loss drug found to address sleep apnoea in trial: Study results could encourage US Medicare system and private insurers to cover tirzepatide ...
ft.com/content/1c7e2db2-1bfd-4882-96d6-b53795844a1b
Alzheimer’s drug Leqembi falls short of blockbuster status in faltering US rollout
ft.com/content/1e02c10c-f7c4-48e9-a6a4-774531b56350
Frozen Russian assets will soon pay for Ukraine’s war: And America now hopes to convince others to make better use of the stash
economist.com/finance-and-economics/2024/04/18/frozen-russian-assets-will-soon-pay-for-ukraines-war
The House of Representatives gives Ukraine its best news in a year: $61bn of aid is on the way. It should have an almost instant effect
economist.com/united-states/2024/04/20/the-house-of-representatives-just-gave-ukraine-the-best-news-it-has-had-for-a-year
How to get more people into military uniforms: Why mandatory military service makes sense for some countries but not others
economist.com/leaders/2024/04/18/how-to-get-more-people-into-military-uniforms
How Iran covered up the damage from Israel’s strikes: New images shared with The Economist show how a swap helped calm a crisis
economist.com/middle-east-and-africa/2024/04/24/how-iran-covered-up-the-damage-from-israels-strikes
Trump v Biden: who’s ahead in the latest polls?: The Economist is tracking the race to be America’s next president
economist.com/interactive/us-2024-election/trump-biden-polls
Most of Lilly's Mounjaro and Zepbound doses in limited supply, FDA says: The U.S. Food and Drug Administration website showed that most doses of Eli Lilly's ...
reut.rs/4d1SgqR
Why the stockmarket is disappearing: Large companies such as ByteDance, OpenAI and Stripe are staying private
economist.com/finance-and-economics/2024/04/18/why-the-stockmarket-is-disappearing
The tiny republic of San Marino is alarmingly friendly to Russia: Intelligence sources are concerned about the country, which is surrounded by Italy
economist.com/europe/2024/04/24/the-tiny-republic-of-san-marino-is-alarmingly-friendly-to-russia
Mayo Clinic RegenBio Summit 2024 registration opens, keynotes announced: Registration is open and keynote speakers for Mayo Clinic RegenBio Summit 2024 include ...
newsnetwork.mayoclinic.org/discussion/mayo-clinic-regenbio-summit-2024-registration-opens-keynotes-announced/
Generation Z is unprecedentedly rich: Millennials were poorer at this stage in their lives. So were baby-boomers
economist.com/finance-and-economics/2024/04/16/generation-z-is-unprecedentedly-rich
Would you really die for your country?: Military conscription is on the agenda in the rich world
economist.com/international/2024/04/17/would-you-really-die-for-your-country
Who will lead the LVMH luxury empire?: Bernard Arnault sizes up his heirs apparent
economist.com/business/2024/04/18/who-will-lead-the-lvmh-luxury-empire
As Russia’s attacks step up, Ukraine fears waning Western support: An interview with the country’s new national security chief
economist.com/europe/2024/04/15/as-russias-attacks-step-up-ukraine-fears-waning-western-support
The growing role of fighting robots on the ground in Ukraine: Drones already fill the skies. Now uncrewed vehicles are heading to the front lines
economist.com/the-economist-explains/2024/04/19/the-growing-role-of-fighting-robots-on-the-ground-in-ukraine
After Dobbs, Americans are turning to permanent contraception: More young women are tying their tubes
economist.com/graphic-detail/2024/04/19/after-dobbs-americans-are-turning-to-permanent-contraception
What to read to understand Chechnya: Four books and a film that unpack an influential region of Russia
economist.com/the-economist-reads/2024/04/16/what-to-read-to-understand-chechnya
Bogus Botox poisoning outbreak spreads to 9 states, CDC says: All of the case have been in women, nine of whom were hospitalized.
arstechnica.com/science/2024/04/bogus-botox-poisoning-outbreak-spreads-to-9-states-cdc-says/
Ukraine is ignoring US warnings to end drone operations inside Russia: Its superdrones can reach targets as far away as Siberia
economist.com/europe/2024/04/18/ukraine-is-ignoring-us-warnings-to-end-drone-operations-inside-russia
U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents: The U.S. Supreme Court on Monday declined to hear a bid by Vanda Pharmaceuticals ...
reuters.com/legal/us-supreme-court-rejects-vanda-pharmaceuticals-case-over-sleep-drug-patents-2024-04-22/
Neumora's early-stage schizophrenia drug study put on hold: Neumora Therapeutics said on Monday the U.S. Food and Drug Administration (FDA) had placed a clinical ...
reut.rs/49wLNBq
What happens if Ukraine loses?: Russian victory would be debilitating for the West, and especially for Europe
economist.com/europe/2024/04/11/what-happens-if-ukraine-loses
A conservative strategist on how Joe Biden can win: Sarah Longwell says “double-haters” will decide the election
economist.com/by-invitation/2024/04/23/a-conservative-strategist-on-how-joe-biden-can-win
Quick Glance: Biden criticizes Florida's abortion ban and holds Trump accountable
- President Biden condemns the upcoming 6-week abortion ban in Florida.
- He blames Trump for appointing justices who overturned Roe v. Wade.
- Biden's campaign focuses on abortion rights to mobilize voters.
- Efforts to leverage Florida's abortion laws for political gain are highlighted.
Without fanfare, the Philippines is getting richer: And its economy is unusually well-defended against American politics
economist.com/asia/2024/04/23/without-fanfare-the-philippines-is-getting-richer
What to read about India’s economy: Can it emulate China’s past manufacturing success—and should it even try?
economist.com/the-economist-reads/2024/04/22/what-to-read-about-indias-economy
The dark side of growing old: A coming wave of Alzheimer’s and other forms of dementia will test China to its limits
economist.com/china/2024/04/18/the-dark-side-of-growing-old
Paid articlePaid
A short history of India in eight maps: Understanding the breathtaking diversity of India and Indians
economist.com/graphic-detail/2024/04/12/a-short-history-of-india-in-eight-maps
Truth Social is a mind-bending win for Donald Trump: And disturbing evidence of how he destabilises reality for Americans
economist.com/united-states/2024/04/18/truth-social-is-a-mind-bending-win-for-donald-trump
FDA classifies recall of Boston Scientific device as 'most serious': The U.S. Food and Drug Administration on Wednesday classified a recall of Boston ...
reuters.com/business/healthcare-pharmaceuticals/fda-classifies-recall-boston-scientific-device-treat-hemorrhaging-most-serious-2024-04-17/
Iran and Israel’s shadow war explodes into the open: But the Islamic Republic may have miscalculated
economist.com/middle-east-and-africa/2024/04/14/iran-and-israels-shadow-war-explodes-into-the-open
What to read about the history of California: Five books that help explain the power and problems of the Golden State
economist.com/the-economist-reads/2024/04/25/what-to-read-about-the-history-of-california
Why is so much of the internet’s infrastructure run by volunteers?: Malware smuggled into XZ Utils software highlights a bigger problem
economist.com/the-economist-explains/2024/04/23/why-is-so-much-of-the-internets-infrastructure-run-by-volunteers
How Hollywood fell in love with video games: “Fallout” is the latest in a successful run of adaptations
economist.com/culture/2024/04/18/how-hollywood-fell-in-love-with-video-games
Ukrainian drone strikes are hurting Russia’s oil industry: The world’s third-largest producer is now an importer of petrol
economist.com/finance-and-economics/2024/04/11/ukrainian-drone-strikes-are-hurting-russias-oil-industry
We've started using a recently FDA-approved ultrasound device to treat liver tumors.
The noninvasive technology uses brief high-intensity ultrasound pulses to ...
cle.clinic/4askbih
Even without war in the Gulf, pricier petrol is here to stay: Expensive oil could put Donald Trump in the White House
economist.com/finance-and-economics/2024/04/17/even-without-war-in-the-gulf-pricier-petrol-is-here-to-stay
The German chancellor’s awkward meeting with China’s boss: It is time for Xi Jinping to accept that Germany isn’t America’s puppet
economist.com/europe/2024/04/18/the-german-chancellors-awkward-meeting-with-chinas-boss
US FDA warns of harmful reactions to fake Botox injections: The U.S. Food and Drug Administration on Tuesday alerted health care professionals and consumers that ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-warns-harmful-reactions-fake-botox-injections-2024-04-16/
3.6 million Medicare enrollees may now be eligible for Wegovy coverage: About 3.6 million Medicare enrollees may qualify for coverage for the anti-obesity drug ...
cnn.com/2024/04/24/health/wegovy-medicare-spending/
The IDF is accused of military and moral failures in Gaza: Its generals botched the strategy, and discipline among troops has broken down
economist.com/middle-east-and-africa/2024/04/11/the-idf-is-accused-of-military-and-moral-failures-in-gaza
Käthe Kollwitz, a pioneering German artist, finally gets her due: Major exhibitions in Frankfurt and New York showcase her portrayals of the scars of war
economist.com/culture/2024/04/19/kathe-kollwitz-a-pioneering-german-artist-finally-gets-her-due
Why do cicadas have such a strange life cycle?: Two broods will soon emerge simultaneously for the first time in 221 years
economist.com/the-economist-explains/2024/04/19/why-do-cicadas-have-such-a-strange-life-cycle
On its 150th anniversary, Impressionism is surprisingly relevant: What the once-derided movement reveals about art today
economist.com/culture/2024/04/18/on-its-150th-anniversary-impressionism-is-surprisingly-relevant
Citigroup, Wall Street’s biggest loser, is at last on the up: Jane Fraser’s unexpected success
economist.com/finance-and-economics/2024/04/18/citigroup-wall-streets-biggest-loser-is-at-last-on-the-up
FDA and USDA food recalls reach highest level since before pandemic: Undeclared allergen, Listeria and Salmonella were the top three reasons for food recalls in ...
axios.com/2024/04/25/food-recall-usda-fda-recalls
Tensions mount between China and the Philippines : The latest incident was just inside the “nine-dash line”
economist.com/asia/2024/04/18/tensions-mount-between-china-and-the-philippines
Next
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics